Atiprimod Completed Phase 2 Trials for Neuroendocrine Carcinomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
https://clinicaltrials.gov/ct2/show/Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma